文献速递重症综合管理与镇静镇痛儿科与产科急症

超声引导下头臂静脉穿刺置入新生儿中心静脉导管的可行性与安全性:多中心观察研究

Safety and Feasibility of Ultrasound-Guided Brachiocephalic Venipuncture for Centrally Inserted Central Catheters in Newborns: A Multicenter Observational Study.
PubMed 文献 · Chest · 2026-08-05
一句话结论在3个III级NICU中,超声引导锁骨上头臂静脉穿刺置入CICC全部成功,首次成功率90.0%,无即刻主要并发症。

所有导管均成功置入,首次穿刺成功率90.0%,平均穿刺尝试1.1次/人。无动脉穿刺、气胸或血胸等即刻主要并发症;导管相关血流感染4.9%(1.7/1000导管日),机械并发症4.1%,二次异位2.7%。研究表明在标准化超声引导方案下,该技术可行、可重复且即刻并发症低,可作为新生儿中心静脉通路的选择。

要点

  • 在3个III级NICU、361例头臂静脉穿刺置入CICC中,所有导管均成功置入,首次穿刺成功率90.0%,平均穿刺尝试1.1次/人。
  • 无即刻主要并发症,包括动脉穿刺、气胸或血胸均未发生。
  • 导管相关血流感染发生率为4.9%(1.7/1000导管日),机械并发症4.1%,二次异位2.7%。
  • 中位置管体重2500 g、中位年龄16天,中位导管留置时间20天,共随访10575导管日。
  • 该技术可作为新生儿中心静脉通路选择,但需在标准化超声引导方案下实施。

适用人群与场景

  • 意大利3个III级NICU中需要置入CICC的危重新生儿,中位置管体重2500 g、中位年龄16天。
  • 排除人群、急诊/院前场景及病情阶段原文未提及。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 在标准化超声引导方案下,行锁骨上头臂静脉穿刺置入CICC。
  • 药物剂量、给药途径、频次或疗程原文未提及。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 所有361例CICC均成功置入,首次穿刺成功325例(90.0%),平均穿刺尝试1.1次/人。
  • 无即刻主要并发症,包括动脉穿刺、气胸或血胸均未发生。
  • 导管相关血流感染18例(4.9%;1.7/1000导管日),机械并发症15例(4.1%),二次异位10例(2.7%)。
  • 中位导管留置时间20天,共10575导管日随访。

证据类型、等级与局限

  • 证据类型为回顾性多中心观察研究(3个III级NICU),证据等级或推荐强度原文未提及。
  • 局限:回顾性设计、样本量361例、仅3个中心、分析为描述性,原文未提及盲法或前瞻性验证。

对床旁实践的改变

  • 在III级NICU中,对需要CICC的危重新生儿,可在标准化超声引导方案下选择锁骨上头臂静脉穿刺,首次成功率高且即刻主要并发症低。
  • 适用与不适用人群、常见陷阱原文未提及。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Ultrasound-guided supraclavicular cannulation of the brachiocephalic vein (BCV) is a promising approach for neonatal central venous access, although multicenter data on feasibility, safety, and reproducibility remain limited.

RESEARCH QUESTION: In critically ill neonates requiring centrally inserted central catheters (CICCs), is ultrasound-guided supraclavicular BCV access feasible across centers, and is it associated with low procedural and catheter-related complication rates?

STUDY DESIGN AND METHODS: This retrospective multicenter observational study was conducted in three Level III neonatal ICUs in Italy and included 361 BCV venipunctures for CICC placement from January 2022 to December 2025. Demographic, procedural, and outcome data were collected from electronic and paper records. Primary outcomes were immediate procedural complications, venipuncture attempts, first-attempt success, and catheter dwell time; secondary outcomes included catheter-related bloodstream infection, mechanical complications, and secondary malposition. Analyses were descriptive.

RESULTS: Median weight at insertion was 2,500 g, and median age was 16 days; median catheter dwell time was 20 days, yielding 10,575 catheter-days of follow-up. All 361 CICCs were successfully placed. First-attempt success occurred in 325 procedures (90.0%), and the mean number of venipuncture attempts was 1.1 per patient. No immediate major complications occurred, including arterial puncture, pneumothorax, or hemothorax. Catheter-related bloodstream infection occurred in 18 catheters (4.9%; 1.7 per 1,000 catheter-days), mechanical complications in 15 (4.1%), and secondary malposition in 10 (2.7%).

INTERPRETATION: Ultrasound-guided supraclavicular BCV catheterization was feasible, reproducible, and associated with low immediate complication rates across 3 neonatal ICUs. These findings support this technique as an effective option for neonatal central venous access when performed within a standardized ultrasound-guided protocol.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Prontera G, Cerreti M, D'Andrea V, et al. Safety and Feasibility of Ultrasound-Guided Brachiocephalic Venipuncture for Centrally Inserted Central Catheters in Newborns: A Multicenter Observational Study. Chest. 2026. PMID: 42556561. doi:10.1016/j.chest.2026.07.5221

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。